| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2017-08-18 |
股东大会：
将于2017-09-27召开股东大会
会议内容 ▼▲
- 1. To consider and vote on a proposal to approve and adopt that certain Agreement and Plan of Merger dated June 7, 2017, which we refer to herein as the merger agreement, by and among SciClone, Silver Biotech Investment Limited, a company organized under the laws of the Cayman Islands, which we refer to herein as Holdco, and Silver Delaware Investment Limited, a Delaware corporation and a wholly-owned subsidiary of Holdco, which we refer to herein as Merger Sub, and approve the merger and other transactions contemplated by the merger agreement. A copy of the merger agreement is attached as Annex A to the accompanying proxy statement;
2. To consider and vote on any proposal to adjourn the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve and adopt the merger agreement and approve the merger at the time of the special meeting;
3. To approve, on an advisory non-binding basis, certain compensation payable or that may become payable to the Company’s named executive officers in connection with the merger.
|
| 2017-08-09 |
详情>>
股本变动：
变动后总股本5219.19万股
|
| 2017-08-09 |
详情>>
业绩披露：
2017年中报每股收益0.52美元,归母净利润2678.80万美元,同比去年增长88.62%
|
| 2017-05-10 |
详情>>
业绩披露：
2017年一季报每股收益0.28美元,归母净利润1459.60万美元,同比去年增长85.61%
|
| 2017-04-28 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- 1.To elect six (6) directors;
2.To hold a non-binding advisory vote to approve named executive officer compensation;
3.To hold a non-binding advisory vote regarding the frequency of future advisory votes on named executive officer compensation;
4.To ratify the appointment of PricewaterhouseCoopers Zhong Tian LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
5.To vote upon a stockholder proposal relating to proxy access, if properly presented at the Annual Meeting;
6.Any other matters that properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2017-03-09 |
详情>>
业绩披露：
2016年年报每股收益0.61美元,归母净利润3072.90万美元,同比去年增长4.30%
|
| 2017-03-09 |
详情>>
业绩披露：
2014年年报每股收益0.49美元,归母净利润2520.80万美元,同比去年增长129.92%
|
| 2016-11-09 |
详情>>
业绩披露：
2016年三季报(累计)每股收益0.49美元,归母净利润2431.80万美元,同比去年增长43.73%
|
| 2016-08-09 |
详情>>
业绩披露：
2016年中报每股收益0.29美元,归母净利润1420.20万美元,同比去年增长187.49%
|
| 2016-05-10 |
详情>>
业绩披露：
2016年一季报每股收益0.16美元,归母净利润786.40万美元,同比去年增长-12.25%
|
| 2016-05-10 |
详情>>
业绩披露：
2015年一季报每股收益0.18美元,归母净利润896.20万美元,同比去年增长116.79%
|
| 2016-04-29 |
股东大会：
将于2016-06-09召开股东大会
会议内容 ▼▲
- 1.To elect six (6) directors;
2.To hold a non-binding advisory vote to approve named executive officer compensation;
3.To approve the adoption of the SciClone Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan (the “Purchase Plan”) and to authorize the sale of up to 2,400,000 shares under the Purchase Plan;
4.To ratify the appointment of PricewaterhouseCoopers Zhong Tian LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
5.To vote upon a stockholder proposal relating to proxy access, if properly presented at the Annual Meeting;
6.Any other matters that properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2016-03-11 |
详情>>
业绩披露：
2015年年报每股收益0.59美元,归母净利润2946.30万美元,同比去年增长16.88%
|
| 2015-11-09 |
详情>>
业绩披露：
2015年三季报(累计)每股收益0.34美元,归母净利润1691.90万美元,同比去年增长-21.99%
|
| 2015-08-10 |
详情>>
业绩披露：
2015年中报每股收益0.10美元,归母净利润494.00万美元,同比去年增长-64.14%
|
| 2015-04-30 |
股东大会：
将于2015-06-11召开股东大会
会议内容 ▼▲
- 1. Election of six (6) directors;
2. A non-binding advisory vote to approve named executive officer compensation;
3. Approval of the adoption of our 2015 Equity Incentive Plan (including, without limitation, certain material terms of such 2015 Plan for purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended);
4. Ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
5. Any other matters that properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2014-04-30 |
股东大会：
将于2014-06-12召开股东大会
会议内容 ▼▲
- 1. Election of six (6) directors;
2. A non-binding advisory vote to approve named executive officer compensation;
3. Ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
4. Any other matters that properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2013-05-23 |
股东大会：
将于2013-06-27召开股东大会
会议内容 ▼▲
- 1. Election of five (5) directors;
2. An advisory vote to approve named executive officer compensation;
3. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013;
4. Any other matters that properly come before the Annual Meeting and any adjournment or postponement thereof.
|
| 2012-06-20 |
复牌提示：
2012-03-02 07:00:12 停牌，复牌日期 2012-03-02 07:30:00
|